Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

Marc A. Bjurlin, Peter R. Carroll, Scott Eggener, Pat F. Fulgham, Daniel J. Margolis, Peter A. Pinto, Andrew B. Rosenkrantz, Jonathan N. Rubenstein, Daniel B. Rukstalis, Samir S. Taneja, Baris Turkbey

    Research output: Contribution to journalArticlepeer-review

    Abstract

    PURPOSE: We update the prior standard operating procedure for magnetic resonance imaging of the prostate, and summarize the available data about the technique and clinical use for the diagnosis and management of prostate cancer. This update includes practical recommendations on the use of magnetic resonance imaging for screening, diagnosis, staging, treatment and surveillance of prostate cancer. MATERIALS AND METHODS: A panel of clinicians from the American Urological Association and Society of Abdominal Radiology with expertise in the diagnosis and management of prostate cancer evaluated the current published literature on the use and technique of magnetic resonance imaging for this disease. When adequate studies were available for analysis, recommendations were made on the basis of data and when adequate studies were not available, recommendations were made on the basis of expert consensus. RESULTS: Prostate magnetic resonance imaging should be performed according to technical specifications and standards, and interpreted according to standard reporting. Data support its use in men with a previous negative biopsy and ongoing concerns about increased risk of prostate cancer. Sufficient data now exist to support the recommendation of magnetic resonance imaging before prostate biopsy in all men who have no history of biopsy. Currently, the evidence is insufficient to recommend magnetic resonance imaging for screening, staging or surveillance of prostate cancer. CONCLUSIONS: Use of prostate magnetic resonance imaging in the risk stratification, diagnosis and treatment pathway of men with prostate cancer is expanding. When quality prostate imaging is obtained, current evidence now supports its use in men at risk of harboring prostate cancer and who have not undergone a previous biopsy, as well as in men with an increasing prostate specific antigen following an initial negative standard prostate biopsy procedure.

    Original languageEnglish (US)
    Pages (from-to)706-712
    Number of pages7
    JournalThe Journal of urology
    Volume203
    Issue number4
    DOIs
    StatePublished - Apr 1 2020

    Keywords

    • image-guided biopsy
    • magnetic resonance imaging
    • prostatic neoplasms
    • risk assessment

    ASJC Scopus subject areas

    • Urology

    Fingerprint

    Dive into the research topics of 'Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer'. Together they form a unique fingerprint.

    Cite this